FDA's MedWatch Program: Voluntarily Reporting Problems to the FDA
Did you know that you can report problems that you have had with drugs and other medical products to the FDA? Did you know that MedWatch can send safety alerts directly to you, as soon as they appear on the web site?
The FDA hosted a webinar “FDA's MedWatch Program: Voluntarily Reporting Problems to the FDA”.
The featured speaker, Cristina Whalen Klafehn PharmD, BCPS, a Health Programs Coordinator in FDA’s Office of Health and Constituent Affairs gave an overview and answered questions about how to report adverse events to MedWatch.
Recorded webinar: https://collaboration.fda.gov/p7m0a8eo69d/
- FDA Basics Metrics: January 2015
- FDA Basics Webinar - November 24, 2014: Drug Shortages
- FDA's MedWatch Program: Voluntarily Reporting Problems to the FDA
- What does FDA regulate?
- What is the Reportable Food Registry?
- How do I report a complaint about food bought in a supermarket?
- What Rules Apply to Persons that Want to Start a Food Business?
- Is "over the counter (OTC)" medication safe for my child?
- What does FDA inspect?
- When and why was FDA formed?
- FDA Basics Metrics: August 2013
- FDA Basics Metrics: September 2013
- What is the FDA doing to protect children from tobacco?
- What is the difference between the Federal Food, Drug, and Cosmetic Act (FD&C Act), FDA regulations, and FDA guidance?
- FDA Basics Metrics: July 2011
- FDA Basics Metrics: June 2011
- FDA Basics Metrics: May 2011
- FDA Basics Metrics: March 2011
- FDA Basics Webinar: Picnic Food Safety, How Safe is Your Picnic?
- Upcoming Webinar Tuesday, March 19th - Buyer Beware:The Risks and Dangers of Purchasing Drugs Online
- What does FDA do?
- How is FDA organized?
- FDA Basics Metrics: February 2013
- What device can I use to monitor the blood sugar level in my child?
- Is it true that "OTC ( Over the Counter)" products can prevent SIDS?
Rate this page
If you would like to ask a specific question, please visit our "Contact Us" page for more information about how to contact FDA.